| The kappa-opioid receptor: evidence for the different subtypes M Wollemann, S Benyhe, J Simon Life sciences 52 (7), 599-611, 1993 | 162 | 1993 |
| Morphine: new aspects in the study of an ancient compound S Benyhe Life sciences 55 (13), 969-979, 1994 | 134 | 1994 |
| Non-opioid actions of opioid peptides M Wollemann, S Benyhe Life sciences 75 (3), 257-270, 2004 | 104 | 2004 |
| Met5‐enkephalin‐Arg 6‐Phe7, an endogenous neuropeptide, binds to multiple opioid and nonopioid sites in rat brain S Benyhe, J Farkas, G Tóth, M Wollemann Journal of neuroscience research 48 (3), 249-258, 1997 | 104 | 1997 |
| Pharmaceutical composition and use A Borsodi, Z Furst, S Hosztafi, SE Varga, T Friedmann, S Benyhe, ... US Patent 5,317,022, 1994 | 103 | 1994 |
| Kinetics and physical parameters of rat brain opioid receptors solubilized by digitonin and CHAPS J Simon, S Benyhe, K Abutidze, A Borsodi, M Szüs, G Toth, M Wollemann Journal of neurochemistry 46 (3), 695-701, 1986 | 71 | 1986 |
| Solubilization and Characterization of Opioid Binding Sites from Frog (Rana esculenta) Brain J Simon, M Szücs, S Benyhe, A Borsodi, P Zeman, M Wollemann Journal of neurochemistry 43 (4), 957-963, 1984 | 63 | 1984 |
| In VitroBinding and Signaling Profile of the Novel μ Opioid Receptor Agonist Endomorphin 2 in Rat Brain Membranes M Spetea, K Monory, C Tömböly, G Tóth, E Tzavara, S Benyhe, ... Biochemical and biophysical research communications 250 (3), 720-725, 1998 | 62 | 1998 |
| Structure− activity study on the Phe side chain arrangement of endomorphins using conformationally constrained analogues C Tömböly, KE Kövér, A Péter, D Tourwé, D Biyashev, S Benyhe, ... Journal of medicinal chemistry 47 (3), 735-743, 2004 | 57 | 2004 |
| Characterization of kappa1 and kappa2 opioid binding sites in frog (rana esculenta) brain membrane preparation S Benyhe, E Varga, J Hepp, A Magyar, A Borsodi, M Wollemann Neurochemical research 15, 899-904, 1990 | 53 | 1990 |
| Noladin ether, a putative endocannabinoid, inhibits μ-opioid receptor activation via CB2 cannabinoid receptors E Páldyová, E Bereczki, M Sántha, T Wenger, A Borsodi, S Benyhe Neurochemistry international 52 (1-2), 321-328, 2008 | 47 | 2008 |
| CB2 cannabinoid receptor antagonist SR144528 decreases mu-opioid receptor expression and activation in mouse brainstem: role of CB2 receptor in pain E Páldy, E Bereczki, M Sántha, T Wenger, A Borsodi, A Zimmer, S Benyhe Neurochemistry international 53 (6-8), 309-316, 2008 | 46 | 2008 |
| Receptor constants for endomorphin-1 and endomorphin-1-ol indicate differences in efficacy and receptor occupancy M Al-Khrasani, G Orosz, L Kocsis, V Farkas, A Magyar, I Lengyel, ... European journal of pharmacology 421 (1), 61-67, 2001 | 45 | 2001 |
| Purification of a kappa-opioid receptor subtype from frog brain J Simon, S Benyhe, J Hepp, A Khan, A Borsodi, M Szucs, ... Neuropeptides 10 (1), 19-28, 1987 | 44 | 1987 |
| Pregnancy-induced decrease in the relaxant effect of terbutaline in the late-pregnant rat myometrium: role of G-protein activation and progesterone R Gáspár, E Ducza, A Mihályi, A Márki, Z Kolarovszki-Sipiczki, E Páldy, ... Reproduction 130 (1), 113-122, 2005 | 43 | 2005 |
| Micromolar concentrations of rimonabant directly inhibits delta opioid receptor specific ligand binding and agonist-induced G-protein activity F Zádor, D Kocsis, A Borsodi, S Benyhe Neurochemistry international 67, 14-22, 2014 | 41 | 2014 |
| Endomorphin-2 with a β-turn backbone constraint retains the potent μ-opioid receptor agonist properties C Tömböly, S Ballet, D Feytens, KE Kövér, A Borics, S Lovas, ... Journal of medicinal chemistry 51 (1), 173-177, 2008 | 40 | 2008 |
| Design, Synthesis and Biological Evaluation of Two Opioid Agonist and Cav2.2 Blocker Multitarget Ligands A Mollica, R Costante, E Novellino, A Stefanucci, S Pieretti, F Zador, ... Chemical biology & drug design 86 (2), 156-162, 2015 | 38 | 2015 |
| Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors A Mollica, S Pelliccia, V Famiglini, A Stefanucci, G Macedonio, ... Journal of Enzyme Inhibition and Medicinal Chemistry 32 (1), 444-451, 2017 | 36 | 2017 |
| Changes in the cannabinoid (CB1) receptor expression level and G-protein activation in kainic acid induced seizures E Bojnik, E Turunç, G Armağan, L Kanıt, S Benyhe, A Yalçın, A Borsodi Epilepsy research 99 (1-2), 64-68, 2012 | 36 | 2012 |
